Research and Reports in Urology is an international, peer-reviewed, open access, online journal.
Publishing original research, reports, editorials, reviews and commentaries on all aspects of adult and pediatric urology in the clinic and laboratory including the following topics:
Pathology, pathophysiology of urological disease
Investigation and treatment of urological disease
Pharmacology of drugs used for the treatment of urological disease
Although the main focus of the journal is to publish research and clinical results in humans; preclinical, animal and in vitro studies will be published where they will shed light on disease processes and potential new therapies.
Issues of patient safety and quality of care will also be considered.
Research and Reports in Urology will no longer consider meta-analyses for publication.
Journal metrics
Usage
64K annual downloads/views
Citation metrics
2.0 (2023) Impact Factor
Q2 Impact Factor Best Quartile
1.9 (2023) 5 year IF
3.4 (2023) CiteScore (Scopus)
Q2 CiteScore Best Quartile
0.902 (2023) SNIP
0.578 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Dr Panagiotis Vlachostergios, Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, United States
Associate Editor-in-Chief:
Dr Guglielmo Mantica, Department of Urology, Policlinico San Martino Hospital – University of Genova, Italy
Editorial Board:
Prof. Dr. Kazem Azadzoi, Department of Urology and Pathology, Bostob University School of Medicine and VA Boston Healthcare System, Boston, MA, USA
Dr Aristotelis Bamias, 2nd Propaedeutic Dept of Internal Medicine, National Kapodistrian University of Athens, Greece
Dr Jens Ceder, Department of Translational Medicine, Division of Urology, Lund University, Sweden
Dr Boris Chertin, The Department of Pediatric Urology, Shaare Zedek Medical Center, Jerusalem, Israel
Prof. Dr. Piergiuseppe Colombo, Department of Pathology, Humanitas University - IRCCS Humanitas Research Hospital, Italy
Dr Roger Dmochowski, Department of Urology, Vanderbilt University Medical Center, United States
Professor Oliver Hakenberg, Urology, Rostock University, Germany
Prof. Dr. Gianni Paulis, Urologist, Andrologist, Peyronie’s Care Center, Rome, Italy
Dr Zhuo Tony Su, MD, Urology Resident Physician, James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, USA
Professor David Waltregny, Urology, Centre Hospitalier Universitaire du Sart Tilm, Belgium
Abstracting and indexing
Research and Reports in Urology is indexed/tracked/covered by the following services:
Directory of Open Access Journals (DOAJ)
EMBASE (Elsevier)
Pubmed (NLM)
PubMed Central Selective Deposit Medicine & Health (NLM)
Scopus (Elsevier)
Open access
Research and Reports in Urology is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110817/Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})